Skip to main content

Court Orders Valsartan Defendants To Submit Primary Findings

Court Orders Valsartan Defendants To Submit Primary Findings

Court Orders Valsartan Defendants To Submit Primary Findings

Introduction

According to a court order dated April 29, valsartan recall defendants should submit their findings outlined in the order by June 17, 2019. The core discovery will be limited only to valsartan medications and not losartan or irbesartan products. Any recall defendants failing to submit the findings should inform the court about their intention by May 27. A telephonic conference will be held on May 8, at 3:00 p.m., to finalize the terms of a Discovery Confidentiality Order, followed by an in-person conference on May 29 to finalize the parties’ Profile Forms and Short Form Complaints, as well as an Order regarding the parties’ group organization and leadership.

The recall began last year after carcinogenic nitrosamines were discovered in active pharmaceuticals ingredients manufactured by Zhejiang Huahai Pharmaceutical Co. which was due to some alteration in its production methods. Research shows nitrosamines are linked to gastrointestinal tract cancers, including colon cancer, stomach cancer, and esophageal cancer. Also, nitrosamines may cause liver cancer, kidney cancer, and pancreatic cancer. There are 50 valsartan lawsuits pending in the federal litigation underway in New Jersey. The proceeding involves over 40 valsartan recall defendants, including Zhejiang Huahai, Teva Pharmaceutical Industries Ltd., Mylan NV, and CVS Health Co.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!